Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-250459
Filing Date
2005-12-29
Accepted
2005-12-29 16:41:11
Documents
11
Period of Report
2005-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 2176509
2 OPTION AGREEMENT WITH MAYO FOUNDATION dex1083.htm EX-10.83 19855
3 AGREEMENT WITH COLLEGIUM PHARMACEUTICAL, INC dex1084.htm EX-10.84 214315
4 PROMISSORY NOTE DATED SEPTEMBER 30, 2005 dex1085.htm EX-10.85 5846
5 CODE OF CONDUCT dex141.htm EX-14.1 101288
6 DIRECTOR INDEMNITY AGREEMENTS dex142.htm EX-14.2 61946
7 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 7304
8 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 7278
9 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3565
10 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3465
11 GRAPHIC g54528img1.jpg GRAPHIC 43902
  Complete submission text file 0001193125-05-250459.txt   2663384
Mailing Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606 8138642562
ACCENTIA BIOPHARMACEUTICALS INC (Filer) CIK: 0001310094 (see all company filings)

EIN.: 000000000
Type: 10-K | Act: 34 | File No.: 000-51383 | Film No.: 051291854
SIC: 2834 Pharmaceutical Preparations